Manish Goel

Manish Goel - SEBI Registered Research Analyst

About Manish Goel

SEBI Registered Research Analyst • Chartered Accountant

377 Articles Published

Manish Goel is a Chartered Accountant, SEBI Registered Research Analyst, and founder of Manish Goel PMS. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.

May 3, 2026
Infographic titled 'Beneish M-Score' showing yearly bar chart (FY20–FY25) with scores: 3.2, 2.8, 2.1, 1.6, 1.3, 1.1 (green FY25 bar).

Beneish M-Score: The 8-Variable Forensic Model That Caught Enron Three Years Before Bankruptcy

The Beneish M-Score is the 8-variable forensic-accounting model published in 1999 that flagged Enron in 1998 — three years before bankruptcy. Learn how to compute it from any Indian annual report, and see why Titan Biotech FY25's 103% CFO/Operating Profit, ₹3 Cr borrowings, ₹7.78 Cr contingent liabilities and 14 board meetings sit deep in the 'unlikely manipulator' zone.
May 3, 2026
Hero section with title 'The Twenty-Punch-Card Rule' and a four-color grid labeled Trader (gray), Compounder (green), Drift (light gray), Speculator (orange).

The Twenty-Punch-Card Rule: Warren Buffett’s Lifetime-Scarcity Discipline for Indian Value Investors

Buffett's twenty-slot punch card forces selectivity, patience and conviction in a single mental model. Titan Biotech's FY25 audited numbers — debt-to-equity 0.02x, ~16.9% RoCE, 103% CFO/operating profit, 55.87% promoter holding — illustrate the discipline.
May 2, 2026
Hero section with the title 'Process vs Outcome Thinking' and green subtitle on a dark blue background; centered, multicolor circular FY25 logo below.

Process vs Outcome Thinking: Annie Duke’s ‘Thinking in Bets’ Framework

A great process can produce a bad year; a bad process can produce a great year. Annie Duke and Michael Mauboussin formalised the discipline that separates them. SEBI's 2025 study shows 91.1% of Indian individual F&O traders lost money in FY24 — a textbook display of 'resulting' at scale. Plus a positive case study of how Titan Biotech's audited FY25 numbers illustrate management process discipline (educational, not a valuation call).
May 2, 2026
Header image: dark blue page with the title "Book Value Per Share (BVPS) Compounding" and a green subtitle; a four-block grid labeled Trader (gray), Compounding (green), Drift (light gray), Speculator (orange).

Book Value Per Share (BVPS) Compounding: Warren Buffett’s 53-Year Berkshire Yardstick

Warren Buffett used Book Value Per Share growth as Berkshire's headline metric for 53 consecutive years from 1965 to 2018. This guide walks Indian retail investors through the formula, the four diagnostic lenses, and uses Titan Biotech FY25 audited numbers as an educational illustration of disciplined long-term equity compounding.
+91-7380122211